Theravance Respiratory Company, LLC - Summary - Summary financial information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Summary financial information
Revenues	$ 13,194	$ 18,257	$ 40,365	$ 53,127
Operating Income (Loss)	(53,615)	(76,615)	(201,617)	(221,267)
Net income	(35,308)	(73,643)	(167,392)	(219,583)
TRC
Summary financial information
Operating Income (Loss)	35,391	15,768	80,244	56,785
Net income	$ 35,539	15,768	$ 79,655	56,822
Percentage of equity interest	85.00%		85.00%
TRC | Royalties
Summary financial information
Revenues	$ 35,585	$ 16,375	$ 84,055	$ 58,143